Arch Chemicals v. Active Concepts
This article was originally published in The Rose Sheet
Executive SummaryPreliminary injunction sought by chemical manufacturer Arch against raw materials supplier Active Concepts is denied in Parsippany, N.J. state court Jan. 22. South Plainfield, N.J.-based Arch filed suit against Active to restrain firm from using or disclosing trade secrets or confidential information it may have obtained by former Arch employees. Trial is slated for Sept. 25, according to Arch, which won an order Dec. 4 restraining Active from disclosing confidential material until after trial...
You may also be interested in...
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.
Two late-stage trials of Austedo have missed their endpoints in the neurological disorder, meaning Teva will miss out on an additional revenue stream from the VMAT2 inhibitor.
Sandoz US president Carol Lynch talked to Scrip about its changing US portfolio, which will emphasize biosimilars, as the Novartis unit is poised to divest most of its US generics portfolio to Aurobindo.